Elevance Health, Inc.
ELV
$389.67
$7.441.95%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.41% | -11.39% | -5.32% | -13.79% | -19.89% |
| Total Depreciation and Amortization | -4.83% | 3.28% | 12.75% | 9.54% | -10.23% |
| Total Amortization of Deferred Charges | 9.40% | 9.40% | 9.40% | 7.15% | 7.15% |
| Total Other Non-Cash Items | -211.45% | -3,127.27% | 133.12% | 74.36% | -58.59% |
| Change in Net Operating Assets | 283.06% | 146.42% | -90.63% | 54.25% | 89.01% |
| Cash from Operations | 15.65% | 56.90% | -26.14% | 130.50% | 212.24% |
| Capital Expenditure | -5.19% | 1.53% | 11.15% | 9.13% | 10.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 101.07% | 102.42% | 101.83% | -228.21% | -254.24% |
| Divestitures | -- | -- | -- | -109.02% | -109.02% |
| Other Investing Activities | -151.23% | -216.20% | -159.07% | 152.68% | 172.74% |
| Cash from Investing | 14.49% | -12.16% | 73.99% | 24.40% | 45.85% |
| Total Debt Issued | -1.91% | -11.90% | -22.43% | 194.31% | 90.86% |
| Total Debt Repaid | -68.54% | -38.97% | -54.80% | -771.53% | -1,749.72% |
| Issuance of Common Stock | 39.08% | -35.37% | -63.35% | -84.08% | -61.84% |
| Repurchase of Common Stock | 14.09% | 16.50% | 12.30% | -87.52% | -25.34% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.99% | -0.26% | -1.39% | -2.97% | -4.89% |
| Other Financing Activities | 347.06% | 306.25% | 1,000.00% | -72.73% | -270.00% |
| Cash from Financing | -104.76% | -213.37% | -245.68% | 7.06% | -150.58% |
| Foreign Exchange rate Adjustments | -2,000.00% | -200.00% | 16.67% | -333.33% | 112.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -130.00% | -114.29% |
| Net Change in Cash | -18.95% | 69.31% | -31.73% | 127.74% | 159.04% |